NT5E and neoplasm: The anti-CD73 antibody isolated by phage display demonstrated anti-tumour activity in a MDA-MB-231 xenograft model and highlights the advantage that isolating a target and an antibody together can accelerate the early validation of that target in a disease relevant setting.